Dudediligence.

Moleculin Biotech, Inc

MBRXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$7.0MSep ’24−$6.6MDec ’24−$5.9MMar ’25−$17.8MJun ’25−$25.4MSep ’25$82.7MDec ’25−$12.8MMar ’26−$7.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income−$23.0M−$30.6M−$29.6M−$26.6M−$25.1M
Net income−$15.9M−$29.0M−$29.8M−$26.0M$33.6M
Operating cash flow−$19.0M−$27.6M−$23.6M−$23.9M−$22.7M
Free cash flow−$19.0M−$27.7M−$23.7M−$23.9M−$22.7M
Cash$70.9M$43.1M$23.6M$4.3M$8.9M
Shares outstanding28.6M1.9M2.2M135.2K3.2M